Zobrazeno 1 - 10
of 66
pro vyhledávání: '"L Prete"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Antonia Moretta, Eugenia Giraldi, Piero De Stefano, Marco Zecca, Daniela Montagna, Franco Locatelli, Rita Maccario, L. Prete, Patrizia Comoli, Cristina Daielli
Publikováno v:
Journal of Clinical Immunology. 16:107-114
Bone marrow transplantation (BMT) from unrelated volunteers is frequently associated with both increased incidence and increased severity of acute graft-versus-host disease (GVHD). In the last years, it has been suggested that the analysis of the fre
Autor:
Cesare Perotti, Rita Balter, Franco Locatelli, Marco Zecca, Daniela Montagna, Pierluigi Marradi, Giovanna Giorgiani, L. Prete
Publikováno v:
Scopus-Elsevier
Two children affected by severe aplastic anaemia and sickle cell anaemia rejected the allogeneic bone marrow transplantation from an HLA-matched unrelated volunteer and an HLA-identical sibling, respectively. In both cases a second transplant using g
Autor:
F, Locatelli, A, Pession, M, Zecca, F, Bonetti, L, Prete, A M, Carrà, A, Prete, D, Montagna, P, Comoli, R M, Taibi, G, Paolucci
Publikováno v:
Bone marrow transplantation. 17(1)
The role of recombinant human granulocyte colony-stimulating factor (rHuG-CSF) in myeloid recovery of children given an allogeneic bone marrow transplant (BMT) from an HLA-identical sibling for acute leukemia was evaluated in a retrospectively histor
Autor:
Mario Cazzola, Paolo Pedrazzoli, Marco Zecca, Luciano Pinto, Anna Maria Carrà, L. Prete, Vittorio Rosti, Franco Locatelli, Patrizia Comoli, Federico Bonetti
In previously published studies on patients with juvenile chronic myelogenous leukemia (JCML), excessive proliferation of malignant monocyte-macrophage elements and impaired growth of normal hematopoietic progenitors were demonstrated. A selective hy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1face47c67f9f29f3b9c06d24c79b84d
http://hdl.handle.net/11573/1491242
http://hdl.handle.net/11573/1491242
Autor:
F, Locatelli, M, Zecca, P, Pedrazzoli, L, Prete, S, Quaglini, P, Comoli, P, De Stefano, Y, Beguin, G, Robustelli della Cuna, F, Severi
Publikováno v:
Bone marrow transplantation. 13(4)
We carried out a pilot study on the use of recombinant human erythropoietin (rHuEPO) in children undergoing allogeneic or mafosfamide-purged autologous BMT for ALL or AML. rHuEPO was administered intravenously at a dose of 75 U/kg/day for 30 days aft
Recombinant human granulocyte-macrophage colony stimulating factor (rHuGM-CSF) in cyclic neutropenia
Autor:
F, Locatelli, P, Pedrazzoli, M, Zecca, R, Maccario, G, Giorgiani, L, Prete, L, Nespoli, F, Severi
Publikováno v:
Haematologica. 76(3)
We describe the case of a 12-year-old boy affected by cyclic neutropenia, at high risk of developing life-threatening infections, treated with recombinant human granulocyte-macrophage colony stimulating factor (rHuGM-CSF). The drug was effective in r
Autor:
F, Locatelli, D, Gambarana, M, Zecca, A, Gibardi, S, Giani, R, Rossi, P, Comoli, L, Prete, F, Bonetti, M, Bozzola
Publikováno v:
Bone marrow transplantation. 8